Kongo review

What it is

Kongo (Kongo Health Inc.) is a no-membership US telehealth platform whose longevity line offers NAD⁺ injections, sermorelin and glutathione at published monthly prices, alongside compounded semaglutide and tirzepatide on the weight-loss side. Intake is a roughly four-minute questionnaire with no video call, a licensed provider reviews it within about 24 hours, and medication is compounded by a licensed US pharmacy and shipped free and discreetly. It states availability in all 50 states and displays a LegitScript seal that verifies against an issued seal ID.

How it works

Asynchronous, fast, and unusually specific about what is bundled: the provider visit, supplies and free shipping are stated as always included, and there is no membership fee — so the monthly figure is the figure. That structure matters more than it sounds. A large share of this board quotes a low medication price and recovers it through a separate membership, a consultation charge or a supplies kit, and Kongo's model removes all three. Its LegitScript seal resolves correctly, and checkout runs through commerce.telegramd.com, which at least traces fulfilment to TelegraMD rather than leaving the chain entirely unnamed — though Kongo itself still describes its pharmacy only as a "licensed US pharmacy" and does not name it. Set against that: it is a newer brand whose main social proof is member testimonials, some verticals are still marked coming soon, and there is no named medical director or physical address published. A three-month plan drops the price a few dollars per month rather than materially.

Pricing transparency

Sermorelin, glutathione and NAD⁺ injections are each $115/mo, dropping to $110/mo for sermorelin and glutathione and $113/mo for NAD⁺ on a three-month plan — with the provider visit, supplies and shipping included and no membership fee. That is a published, flat, per-molecule figure with the extras folded in, which is exactly what this board usually refuses to give you and the main reason to look at Kongo at all. Its GLP-1 pricing is separately notable at $119/mo for compounded semaglutide and $229/mo for tirzepatide, but those are weight-loss numbers and are not a peptide price. The one thing to establish yourself is what a month actually contains — dose and vial size are not stated next to the price, and $115 for a small vial is not the same purchase as $115 for a large one. Cancellation is described as no-membership with nothing to cancel beyond the order, but get the refill cadence in writing before the first shipment.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Kongo discloses the compounded status and states that a licensed US pharmacy prepares the medication, but does not name it, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the three molecules at $115 are not equivalent purchases. Sermorelin is a GHRH analogue that stimulates the pituitary to release your own growth hormone, preserving the somatostatin feedback loop that exogenous HGH overrides — a real, well-characterised mechanism, with human outcome data that thins out badly beyond short-term IGF-1 changes. Injected NAD⁺ has no controlled human outcome trials at all; the single human intravenous study was a pharmacokinetic pilot finding that infused NAD⁺ clears from plasma quickly, and the NAD⁺ forms with human trial data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker rather than a demonstrated clinical benefit. Injectable glutathione has essentially no controlled human outcome data behind the detoxification and skin claims attached to it. Individual results vary.

Pros and watch-outs

The evidence behind what Kongo prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How Kongo compares

A few alternatives worth a look, depending on what you’re optimizing for.

• LILiberty

  NAD⁺ from a platform that sources through 503B outsourcing facilities nationwide

  See Liberty →
• LTLttl

  Shoppers who want every commitment tier priced openly before they hand over anything

  See Lttl →
• LRLevelUp Rx

  NAD⁺ injections from a platform that names the pharmacies dispensing them

  See LevelUp Rx →